Does NEBIVOLOL Cause Potentiating drug interaction? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Potentiating drug interaction have been filed in association with NEBIVOLOL (nebivolol). This represents 0.1% of all adverse event reports for NEBIVOLOL.
5
Reports of Potentiating drug interaction with NEBIVOLOL
0.1%
of all NEBIVOLOL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Potentiating drug interaction From NEBIVOLOL?
Of the 5 reports, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Potentiating drug interaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NEBIVOLOL Cause?
Hypotension (487)
Drug ineffective (430)
Bradycardia (371)
Dyspnoea (364)
Fall (320)
Acute kidney injury (300)
Dizziness (294)
Off label use (277)
Fatigue (257)
Hypertension (249)
What Other Drugs Cause Potentiating drug interaction?
METFORMIN (150)
METHOTREXATE (119)
QUETIAPINE (98)
ASPIRIN (87)
RIVAROXABAN (71)
PREGABALIN (67)
TACROLIMUS (56)
AMIODARONE (53)
CLARITHROMYCIN (52)
GABAPENTIN (52)
Which NEBIVOLOL Alternatives Have Lower Potentiating drug interaction Risk?
NEBIVOLOL vs NECITUMUMAB
NEBIVOLOL vs NEDAPLATIN
NEBIVOLOL vs NEFAZODONE
NEBIVOLOL vs NEFOPAM
NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG